Global Diagnostics Immundiagnostik AG operates in over 30 countries with a broad product portfolio of immunoassays, antibodies, and antigens, presenting a wide cross-border sales opportunity for diagnostic distributors, contract research organizations, and clinical labs seeking expanded assay offerings.

Clinical Trial Focus The company engages in contract analyses for diagnostic laboratories and academic research, particularly in clinical trials, suggesting upsell and partnership opportunities with CROs, research labs, and pharma collaborators needing assay development, validation, and outsourcing capabilities.

New Platforms Recent launches of the ECL100 Chemiluminescent Immunoassay Analyzer and QSE180 Autosampler indicate a push into automated chemiluminescent workflows, signaling a potential sales path to laboratories upgrading automation and throughput in clinical chemistry.

Digital & Outreach Active use of digital marketing and analytics tools (Google Ads, Matomo, Piwik PRO) along with a public-facing website expansion position Immundiagnostik as accessible for distributor partnerships, online education programs, and lead-generation collaborations.

Mid-Sized Growth With 51-200 employees and revenue in the lower millions, the company represents a mid-sized, growth-focused partner ideal for channel partnerships, value-added reselling, and co-development agreements with feasible investment and manageable onboarding for new markets.